SCHEDULE 13G/A: FMR LLC and Abigail Johnson Maintain Significant Passive Stake in Tectonic Therapeutic Inc.
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have disclosed a continued 10.3% passive ownership stake in TECTONIC THERAPEUTIC INC as of December 31, 2024, through an Amendment No. 2 to their Schedule 13G filing.
Summary
- FMR LLC and Abigail P. Johnson filed an Amendment No. 2 to Schedule 13G concerning their beneficial ownership in TECTONIC THERAPEUTIC INC.
- As of December 31, 2024, FMR LLC and Abigail P. Johnson collectively beneficially own 1,516,335 shares of TECTONIC THERAPEUTIC INC common stock.
- This ownership represents 10.3% of the total outstanding common stock of TECTONIC THERAPEUTIC INC.
- The shares are held for investment purposes in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- FMR LLC, a Delaware-organized entity, is identified as a parent holding company, with subsidiaries like FIAM LLC, Fidelity Management & Research Company LLC, and Fidelity Management Trust Company involved in the beneficial ownership.
- Abigail P. Johnson, a U.S. citizen, is reported as a beneficial owner, also serving as a Director, Chairman, and Chief Executive Officer of FMR LLC, with the Johnson family holding predominant ownership of FMR LLC's voting shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently sway sentiment positively or negatively regarding the issuer's operational performance or financial health.
Positives
- The disclosure of a significant 10.3% stake by a major institutional investor like FMR LLC and its affiliates may be viewed as a positive signal of confidence in TECTONIC THERAPEUTIC INC.
Industry Context
This filing represents a routine disclosure by a large institutional asset manager, FMR LLC (Fidelity), of its passive ownership stake in a publicly traded company, TECTONIC THERAPEUTIC INC. Such significant holdings by major investment firms are common across various industries, including the therapeutic sector, and typically reflect an investment strategy rather than an intent to influence corporate control.
Stakeholder Impact
- Shareholders: The disclosure indicates a significant, passive institutional investment, which may be perceived as a vote of confidence in the company by a major asset manager.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/10/2023 | Date of initial Schedule 13G filing by FMR LLC (accession number: -23-000003). |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 01/31/2023 | Date of Schedule 13G filing by FMR LLC (accession number: -23-000038). |
| 12/31/2024 | Date of event which requires the filing of this statement (reporting period end). |
| 01/07/2025 | Signature date of the current Schedule 13G Amendment No. 2 filing. |
Keywords
TECTONIC THERAPEUTIC INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, Passive Investment, Fidelity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.